The use of ticagrelor in acute coronary syndromes

Aydoğdu, Sinan; Özcan Çelebi, Özlem

Journal Metrics

Impact Factor (2022): 0.8
CiteScore (2022): 1.2
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

52/3Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and

In titles and abstracts

In keywords

In all

Archives of the Turkish Society of Cardiology

pdf

The use of ticagrelor in acute coronary syndromes [Turk Kardiyol Dern Ars]

Turk Kardiyol Dern Ars. 2013; 41(1): 12-16

The use of ticagrelor in acute coronary syndromes

Sinan Aydoğdu¹, Özlem Özcan Çelebi²
¹Turkey High Specialization Hospital Cardiology Clinic, Ankara, Turkey
²Medicine International Ankara Hospital, Cardiology Clinic, Ankara, Turkey

Acute coronary syndrome plays a major role in the treatment of acute coronary syndrome. New agents have been developed and introduced into clinical practice while dual antiplattelet therapy has been limited with clopidogrel until recently. In this review we summarize the efficacy of ticagrelor, a new antiplatelet agent.

How to cite this article
Sinan Aydoğdu, Özlem Özcan Çelebi. The use of ticagrelor in acute coronary syndromes. Turk Kardiyol Dern Ars. 2013; 41(1): 12-16

Corresponding Author: Sinan Aydoğdu, Türkiye
Manuscript Language: Turkish

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar